Page 6 of articles about vaccine in Press releases

Inovio Pharmaceuticals, Inc., a leader in the development of synthetic immunogens against cancers and infectious diseases, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Department of Homeland Security (DHS) Science and Technology Directorate Plum Island Animal Disease Center. This collaboration will evaluate the efficacy of Inovio's SynCon® vaccines for foot & mouth disease (FMD) in important animal models including cattle, sheep, and pigs.

Canadian swine producers can now vaccinate for mycoplasma pneumonia when they process baby pigs. A new label claim makes RespiSure-ONE the only vaccine approved for administration at one day of age.

Nearly every pig in Canada receives a vaccine for protection against porcine circovirus (PCV), and now swine producers have a new option for efficacious protection with the registration of Fostera PCV from Pfizer Animal Health.

Merck Animal Health (MSD Animal Health outside the USA and Canada), formerly known as Intervet/Schering-Plough Animal Health, has opened today an expansion of a vaccine manufacturing unit at its Elkhorn Biotechnology Excellence Center.

South Dakota State University is partnering with animal health leader Boehringer Ingelheim Vetmedica, Inc. to develop a new technology to protect pigs against a deadly form of E. coli.

Merck Animal Health, formerly known as Intervet/Schering-Plough Animal Health, announced today that it has embarked on the expansion of a vaccine manufacturing unit at its Biosciences Center Boxmeer campus in the Netherlands.

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that its Chief Veterinary Scientific Officer, Dr. Dragan Rogan, was an invited speaker at the 56th International Meat Industry Conference being held in Tara, Serbia.

Intervet/Schering-Plough Animal Health announces today that it is introducing PORCILIS® AR-T DF, an inactivated vaccine against progressive atrophic rhinitis in piglets with a new adjuvant associated with fewer injection site reactions.

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today officially opened its new Animal Health and Food Safety Vaccine Manufacturing Centre at its corporate headquarters in Belleville, Ontario, Canada.

Intervet/Schering-Plough Animal Health announces today that a field trial with the single-dose subunit vaccine PORCILIS® PCV has confirmed that vaccination induces humoral and cellular immunity and protects piglets against the consequences of porcine circovirus-associated disease (PCVD).

Virbac, the 8th largest veterinarian pharmaceutical group worldwide, has concluded an exclusive Distribution and Trademark Licence Agreement with Prevtec microbia, a Canadian veterinarian laboratory, for the distribution of the Coliprotec® vaccine in Brazil.

Intervet/Schering-Plough Animal Health announces today that it has shipped 12 million doses of foot-and-mouth disease (FMD) vaccine to South Korea to assist in the country’s efforts to halt the ongoing FMD outbreak.

On November 29th 2010, CIRCOVAC was granted a European marketing authorization for use in piglets. CIRCOVAC is now the first PCVD vaccine available worldwide for the vaccination of both sows and piglets; it is registered in Europe, Brazil, Mexico and Thailand.

Intervet/Schering-Plough Animal Health announced that it has opened a specialized filling and freeze-drying unit for veterinary vaccines at its Biosciences Center Boxmeer in the Netherlands. The opening of the Central Filling and Freeze-drying Department was performed by her Royal Highness Princess Máxima of the Netherlands in the presence of His Excellency the Minister of Economic Affairs, Agriculture and Innovation, Maxime Verhagen, and other guests.

Pork producers in US can now vaccinate for mycoplasmal pneumonia at day one.

Simultaneous (mixed) use of existing swine vaccines against porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo) from Intervet/Schering-Plough Animal Health in swine are as efficacious and safe as separate use of these vaccines.